Clinical Trials Browser

Phase 2 × Urethral Neoplasms × Fluorodeoxyglucose F18 × Clear all

NCT01031875 2013-08-12

Pazopanib Hydrochloride in Treating Patients With Metastatic Urethral Cancer or Bladder Cancer That Has Relapsed or Not Responded to Treatment

Phase 2 Completed

Urinary Bladder Neoplasms, Urethral Neoplasms